Bast, RC Jr, Feeney, M, Lazarus, H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331–7.CrossRefGoogle ScholarPubMed

Davis, AM, Zurawski, VR, Bast, RC, et al. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res 1986;46:6143–8.Google ScholarPubMed

Kuzuya, K, Nozaki, M, Chihara, T. Evaluation of CA 125 as a circulating tumor marker for ovarian cancer. Acta Obstet Gynecol Jpn 1986;38:949–57.Google Scholar

O’Brien, TJ, Raymond, LM, Bannon, GA, et al. New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitope. Am J Obstet Gynecol 1991;165:1857–64.Google ScholarPubMed

Allison, J, Hall, L, Maclntyre, I, et al. The construction and partial characterisation of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochem J 1981;199:725–31.Google Scholar

Saad, MF, Ordonez, NG, Guido, JJ, et al. The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid. J Clin Endocrinol Metab 1984;59:850–6.Google Scholar

Miettinen, MM, Sarloma-Rikala, M, Kovatich, AJ, et al. Calponin and h-Caldesmon in soft tissue tumors: Consistent h-Caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol 1999;12:756–62.Google ScholarPubMed

Savera, AT, Gown, AM, Zarbo, RJ. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: Assessment of the morphogenetic role of myoepithelium. Mod Pathol 1997;10:1093–100.Google ScholarPubMed

Andrici, J, Farzin, M, Clarkson, A, et al. Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms. Pathology 2016;48:319–24.Google Scholar

Kabbage, M, Trimeche, M, Bergaoui, S, et al. Calreticulin expression in infiltrating ductal breast carcinomas: Relationships with disease progression and humoral immune responses. Tumour Biol 2013;34:1177–88.Google Scholar

Barberis, MCP, Faleri, M, Veronese, S, et al. Calretinin: A selective marker of normal and neoplastic mesothelial cells in serous effusions. Acta Cytol 1997;41:1757–61.Google Scholar

Cao, QJ, Jones, JG, Li, M . Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 2001;20:346–52.Google Scholar

Dei Tos, AP, Doglioni, C. Calretinin: A novel tool for diagnostic immunohistochemistry. Adv Anat Pathol 1998;5:61–6.Google Scholar

Monteagudo, C, Marcilla, A, Mormeneo, S, et al. Specific immunohistochemical identification of Candida albicans in paraffin-embedded tissue with a new monoclonal antibody (1B12). Am J Clin Pathol 1995;103:130–5.Google Scholar

Williams, DW, Jones, HS, Allison, RT, et al. Immunocytochemical detection of Candida albicans in formalin fixed, paraffin embedded material. J Clin Pathol 1998;51:857–9.Google Scholar

Al-Ahmadie, HA, Alden, D, Qin, L-X, et al. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: An immunohistochemical study comparing 2 antibodies. Am J Surg Pathol 2008;32: 377–82.Google Scholar

Bing, Z, Lal, P, Lu, S, et al. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: A tissue microarray immunohistochemical study. Ann Diagn Pathol 2013;17:58–62.Google Scholar

Bui, MH, Visapaa, H, Seligson, D, et al. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. J Urol 2004;171:2461–6.Google Scholar

Genega, E, Ghebremichael, M, Najarian, R, et al. Carbonic anhydrase IX in renal neoplasms. Correlation with tumor type and grade. Am J Clin Pathol 2010;134:873–9.CrossRefGoogle ScholarPubMed

Stillebroer, AB, Mulders, PFA, Boerman, OC, et al. Carbonic anhydrase IX in renal cell carcinoma: Implications for prognosis, diagnosis and therapy. Eur Urol 2010;58:75–83.CrossRefGoogle ScholarPubMed

Robb, JA. Mesothelioma versus adenocarcinoma: False positive CEA and Leu-M1 staining due to hyaluronic acid (Letter). Hum Pathol 1989;20:400.Google Scholar

Birchmeier, W, Behrens, J. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994;1198:11–26.Google Scholar

Hinck, L, Nathke, IS, Papkoff, J, et al. Dynamics of cadherin/catenin complex formation: Novel protein interactions and pathways of complex assembly. J Cell Biol 1994;125:1327–40.Google Scholar

Leto, G, Gebbia, N, Rausa, L, et al. Cathepsin D in the malignant progression of neoplastic diseases (review). Anticancer Res 1992;12:235–40.Google ScholarPubMed

Schwartz, MK. Tissue cathepsins as tumor markers. Clin Chim Acta 1995;237:67–78.Google Scholar

Chancellor, A, Gadola, SD, Mansour, S. The versatility of the CD1 lipid antigen presentation pathway. Immunology 2018;154:196–203.CrossRefGoogle ScholarPubMed

Krenacs, L, Tiszalvicz, LT, Krenacs, T, et al. Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol 1993; 171: 99–104.CrossRefGoogle ScholarPubMed

Porcelli, SA, Modlin, RL. CD 1 and the expanding universe of T cell antigens. J Immunol 1995;55:709–10.Google Scholar

Binder, C, Cvetkovski, F, Sellberg, F, et al. CD2 immunobiology. Front Immunol 2020;11:1090.CrossRefGoogle ScholarPubMed

Gonzalez, L, Anderson, I, Deane, D, et al. Detection of immune system cells in paraffin wax-embedded ovine tissues. J Comp Pathol 2001; 125: 41–7.CrossRefGoogle ScholarPubMed

Birnbaum, ME, Berry, R, Hsiao, Y-S, et al. Molecular architecture of the ab T cell receptor-CD3 complex. Proc Natl Acad Sci 2014;111:17,576–81.CrossRefGoogle Scholar

Chetty, R, Gatter, K. CD3 structure, function, and role of immunostaining in clinical practice. J Pathol 1994:173; 303–7.Google Scholar

Brady, RL, Barclay, AN. The structure of CD4. Curr Top Microbiol Immunol 1996;205:1–18.Google Scholar

Arber, DA, Weiss, LM. CD5: A review. Appl Immunohistochem 1995;3: 1–22.Google Scholar

Lazarovits, AI, Osman, N, Le Feuvre, CE, et al. CD7 is associated with CD3 and CD45 in human T cells. J Immunol 1994:153;3956–66.Google Scholar

Saati, TA, Alibaud, L, Lamant, L, et al. A new monoclonal anti-CD7 antibody reactive in paraffin sections. Appl Immunohistochem Mol Morphol 2001;9:289–96.Google Scholar

Eichmann, K, Boyce, NW, Schmidt, UR, et al. Distinct functions of CD8 (CD4) are utilised at different stages of T lymphocyte differentiation. Immunol Rev 1989;109:39–75.Google Scholar

Martz, E, Davignon, D, Kurzinger, K, et al. The molecular basis for cytotoxic T lymphocyte function: Analysis with blocking monoclonal antibodies. Adv Exp Med Biol 1982;146:447–65.Google Scholar

Parnes, JR. Molecular biology and function of CD4 and CD8. Adv Immunol 1989;44:265–311.Google Scholar

Carbone, A, Poletti, A, Manconi, R, et al. Heterogenous in situ immunotyping of follicular dendritic reticulum cells in malignant lymphomas of B cell origin. Cancer 1987;60:2919–26.3.0.CO;2-Z>CrossRefGoogle Scholar

Lardelli, P, Bookman, MA, Sundeen, J, et al. Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990;14:752–63.Google Scholar

San Miguel, JF, Caballero, MD, Gonzalez, M, et al. Immunological phenotype of neoplasms involving the B cell in the last step of differentiation. Br J Haematol 1986;62:75–83.Google Scholar

Chu, P, Arber, D. Paraffin section detection of CD10 in 505 non-hematopoietic neoplasms: Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000;113:374–82.CrossRefGoogle Scholar

Maguer-Sata, V, Besançon, R, Bachelard-Cascales, E. Concise review: Neutral endopeptidase (CD10): A multifaceted environment actor in stem cells, physiological mechanisms and cancer. Stem Cells 2011;29:389–96.Google Scholar

Chadburn, A, Inghirami, G, Knowles, DM. Hairy cell leukemia-associated antigen Leu M5 (CD11c) is preferentially expressed by benign activated and neoplastic CD8 cells. Am J Pathol 1990;136:29–37.Google Scholar

Aber, DA, Weiss, LM. CD15: A review. Appl Immunohistochem 1993;1:17–30.Google Scholar

Bruhns, P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 2012;119(24):5640–9.Google Scholar

Cherian, S and Wood, B. ed. Flow cytometry in evaluation of hematopoietic neoplasms. CAP, Northfield, Illinois, 2012.Google Scholar

Feng, R, Bhatt, VR, Fu, K, Pirruccello, S, et al. Application of immunophenotypic analysis in distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Cytometry B Clin Cytom 2018;94(6):901–9.Google Scholar

Qubaja, M, Marmey, B, Tourneau, AL, et al. The detection of CD14 and CD16 in paraffin-embedded bone marrow biopsies is useful for the diagnosis of chronic myelomonocytic leukemia. Virchows Arch 2009;454(4):411–19.Google Scholar

Zhang, Y, Boesen, CC, Radaev, S, et al. Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity 2000;13(3):387–95.CrossRefGoogle ScholarPubMed

Otero, DC, Anzelon, AN, Rickert, RC. CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals. J Immunol 2003;170:73–83.Google Scholar

Otero, DC, Rickert, RC. CD19 function in early and late B cell development: II. CD19 facilitates the pro-B/pre-B transition. J Immunol 2003;171:5921–30.Google Scholar

Pavlasova, G, Mraz, M. The regulation and function of CD20: An “enigma” of B-cell biology and targeted therapy. Haematologica 2020;105:1494–506.CrossRefGoogle ScholarPubMed

Bellizzi, AM, Montgomery, EA, Hornick, JL. American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples – gastrointestinal mucosal biopsies. Ann Diagn Pathol 2020;44:151419.Google Scholar

Bagdi, E, Krenacs, L, Krenacs, T, et al. Follicular dendritic cells in reactive and neoplastic lymphoid tissues: A reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval. Appl Immunohistochem Mol Morphol 2001;9:117–24.Google Scholar

Hannan, JP. The structure-function relationships of complement receptor type 2 (CR2; CD21). Curr Protein Pept Sci 2016;17(5):463–87.Google Scholar

Acharya, M, Borland, G, Edkins, AL, et al. CD23/FcεRII: Molecular multi-tasking. Clin Exp Immunol 2010;162(1):12–23.CrossRefGoogle ScholarPubMed

Abramson, CS, Kersey, JH, LeBien, TW. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage. J Immunol 1981;126:83–8.CrossRefGoogle ScholarPubMed

Bayer, AL, Pugliese, A, Malek, TR. The IL-2/IL-2 R system: From basic science to therapeutic applications to enhance immune regulation. Immunol Res 2013;57(1–3):197–209. doi:10.1007/s12026-013-8452-5Google Scholar

O’Malley, DP, Chizhevsky, V, Grimm, KE, et al. Utility of BCL2, PD1, and CD25 immunohistochemical expression in the diagnosis of T cell lymphomas. Appl Immunohistochem Mol Morphol 2014;22:99–104.CrossRefGoogle ScholarPubMed

Hang, KL, Arber, DA, Weiss, LM. CD30: A review. Appl Immunohistochem 1993;1:244–55.Google Scholar

So, T, Ishii, N. The TNF-TNFR family of co-signal molecules. Adv Exp Med Biol 2019;1189:53–84.CrossRefGoogle ScholarPubMed

Xu, ML, Gabali, A, Hsi, ED, et al. Practical approaches on CD30 detection and reporting in lymphoma diagnosis. Am J Surg Pathol 2020;44(2):e1–e14.Google Scholar

Albelda, SM, Muller, WA, Buck, CA, et al. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:1059–61.Google Scholar

DeYoung, BR, Wick, MR, Fitzgibbon, JF, et al. CD 31: An immunospecific marker for endothelial differentiation in human neoplasms. Appl Immunohistochem 1993;1:97–100.Google Scholar

Stokinger, H, Gadd, SJ, Eher, R, et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol 1990;145:3889–97.Google Scholar

Suthipintawong, C, Leong, AS-Y, Vinyuvat, S. A comparative study of immunomarkers for lymphangiomas and hemangiomas. Appl Immunohistochem 1995;3:239–44.Google Scholar

Teo, NB, Shoker, BS, Jarvis, C, et al. Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. Br J Cancer 2002;86:905–11.Google Scholar

Bovio, I, Allan, RW. The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK+ anaplastic large cell lymphomas. Am J Clin Pathol 2008; 130: 628–34.CrossRefGoogle ScholarPubMed

Crocker, PR, McMillan, SJ, Richards, HE. CD33-related siglecs as potential modulators of inflammatory responses. Ann NY Acad Sci 2012;1253:102–111.Google Scholar

Hoyer, JD, Grogg, KL, Hanson, CA, et al. CD33 detection by immunohistochemistry in paraffin-embedded tissues: A new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage. Am J Clin Pathol 2008; 129: 316–23.Google Scholar

Sidney, LE, Branch, MJ, Dunphy, SE, et al. Concise review: Evidence for CD34 as a common marker for diverse progenitors. Stem Cells 2014;32:1380–9.Google Scholar

Hughes, MR, Hernaez, DC, Cait, J, et al. A sticky wicket: Defining molecular functions for CD34 in hematopoietic cells. Exp Hematol 2020;86:1–14.Google Scholar

Badgi, E, Krenacs, L, Krenacs, T, et al. Follicular dendritic cells in reactive and neoplastic lymphoid tissues: A reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval. Appl Immunohistochem 2001;9:117–24.Google Scholar

Liu, D, Niu, Z-X. The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35). Immunopharmacol Immunotoxicol 2009;31:524–35.Google Scholar

Morandi, F, Airoldi, I, Marimpietri, D, et al. CD38, a receptor with multifunctional activities: From modulatory functions on regulatory cell subsets and extracellular vesicles, to a target for therapeutic strategies. Cells 2019;8:1527.CrossRefGoogle ScholarPubMed

Carbone, A, Gloghini, A, Gruss, HJ, et al. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin’s disease. Am J Pathol 1995;147:912–22.Google Scholar

Flavell, DJ, Flavell, SU, Jones, DB, et al. Two new monoclonal antibodies recognising T-cells (DF-T1) and B-cells (DF-B1) in formalin fixed paraffin embedded tissue sections. J Pathol 1988;155:343A.Google Scholar

Poppema, S, Hollema, H, Visser, L, et al. Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol 1987;127:418–29.Google Scholar

East, JE, Hart, IR. CD 44 and its role in tumor progression and metastasis. Eur J Cancer 1993;29A: 1921–2.Google Scholar

Poppema, S, Lai, R, Visser, L. Monoclonal antibody OPD4 is reactive with CD45RO but differs from UCHL1 by the absence of monocyte activity. Am J Pathol 1991;139:725–9.Google Scholar

Weiss, LM, Arber, DA, Chang, KL. CD45: A review. Appl Immunohistochem 1993;1:166–81.Google Scholar

Ohh, M, Takei, F. New insights into the regulation of ICAM-1 gene expression. Leuk Lymphoma 1996;20:223–8.Google Scholar

Chan, JKC. CD56-positive putative natural killer (NK) cell lymphomas: Nasal, nasal-type, blastoid, and leukemic forms. Adv Anat Pathol 1997;4:163–72.Google Scholar

Arber, DA, Weiss, LM. CD57: A review. Appl Immunohistochem 1995;3:137–52.Google Scholar

Pulford, KAF, Rigney, EM, Micklem, KJ, et al. KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989;42:414–21.Google Scholar

Pulford, KAF, Sipos, A, Cordell, JL, et al. Distribution of the CD68 macrophage/myeloid associated antigen. Immunology 1990;2:973–80.Google Scholar

Dong, H., Wilkes, S., Yang, H. CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: A comparative immunochemical study with glycophorin A and hemoglobin A. Am J Surg Path 2011;35:723–32.Google Scholar

Marsee, D., Pinkus, G. S., Yu, H. CD71 (transferrin receptor): An effective marker for erythroid precursors in bone marrow biopsy specimens. Am J Clin Path 2010;134:429–35.Google Scholar

Schroder, B. The multifaceted roles of the invariant chain CD74: More than just a chaperone. Biochem Biophys Acta Mol Cell Res 2016;1863:1269–81.Google Scholar

Chu, PG, Arber, DA. CD79: A review. Appl Immunohistochem Mol Morphol 2001;9:97–106.Google Scholar

Mason, DY, Cordell, JL, Brown, MH, et al. CD79a: A novel marker for B cell neoplasms in routinely processed tissue samples. Blood 1995;86:1453–9.CrossRefGoogle Scholar

Stevenson, AJ, Chatten, J, Bertoni, F, et al. CD99 (p30/32MIC2) neuroectodermal/Ewing’s sarcoma antigen as an immunohistochemical marker: Review of more than 600 tumors and the literature experience. Appl Immunohistochem 1994;2:231–40.Google Scholar

Vartanian, RK, Sudilovsky, D, Weidner, N. Immunostaining of monoclonal antibody 013 (anti MIC2 gene product) (CD99) in lymphomas: Impact of heat-induced epitope retrieval. Appl Immunohistochem 1996;4:43–55.Google Scholar

Weidner, N, Tjoe, J. Immunohistochemical profile of monoclonal antibody 013: Antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing’s sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18:486–94.Google Scholar

Ebert, MP, Ademmer, K, Muller-Ostermeyer, F, et al. CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am J Gastroenterol 1998;93:2141–7.Google Scholar

Pauls, K, Schon, M, Kubitza, RC, et al. Role of integrin alphaE (CD 103) beta 7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol 2001;117:569–75.Google Scholar

Gibson, PC, Cooper, K. GD117 (KIT): A diverse protein with selective applications in surgical pathology. Adv Anat Pathol 2002;9:65–9.Google Scholar

Miettinen, M, Lasota, J. KIT (CD117): A review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 2005;13:205–20.Google Scholar

Del Giudice, I, Matutes, E, Morilla, R, et al. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes. Haematologica 2004;89(3):303–8.Google Scholar

Kussick, SJ, Stirewalt, DL, Yi, HS, et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia 2004;18(10):1591–8.Google Scholar

Kambham, N, Kong, C, Longacre, TA, et al. Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: A tissue microarray study of 1,754 cases. Appl Immunohistochem Mol Morphol 2005;13: 304–10.Google Scholar

O’Connell, FP, Pinkus, JL, Pinkus, GS. CD138 (syndecan-1), a plasma cell marker: Immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol 2004;121:254–63.Google Scholar

Klein, JL, Nguyen, TT, Bien-Willner, GA, et al. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma. Am J Clin Pathol 2014;141:381–7.Google Scholar

Kridel, R, Xerri, L, Gelas-Dore, B, et al. The prognostic impact of CD163-positive macrophages in follicular lymphoma: A study from the BC Cancer Agency and the Lymphoma Study Association. Clin Cancer Res 2015;21:3428–35.Google Scholar

Lau, SK, Chu, PG, Weiss, LM. CD163: A specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 2004;122:794–801.Google Scholar

Nguyen, TT, Schwartz, EJ, West, RB, et al. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 2005;29:617–24.CrossRefGoogle Scholar

Binh, MB, Sastre-Garau, X, Guillou, L, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: A comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005;29:1340–7.CrossRefGoogle ScholarPubMed

Coindre, JM, Hostein, I, Maire, G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: Histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 2004;203(3):822–30.Google Scholar

Dei Tos, AP, Doglioni, C, Piccinin, S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 2000;190:531–6.Google Scholar

Dujardin, F, Binh, MB, Bouvier, C, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 2011;24:624–37.Google Scholar

Thway, K, Flora, R, Shah, C, et al. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol 2012;36(3):462–9.Google Scholar

Dunphy, CH, Polski, JM, Lance Evans, H, et al. Paraffin immunoreactivity of CD10, CDw75 and bcl-6 in follicle center cell lymphoma. Leuk Lymphoma 2001;41:585–92.CrossRefGoogle ScholarPubMed

Bellizzi, AM. Assigning site of origin in metastatic neuroendocrine neoplasms: A clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol 2013;20:285–314.Google Scholar

Freund, JN, Domon-Dell, C, Kedinger, M, et al. The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol 1998;76:957–69.Google Scholar

Jaffee, IM, Rahmani, M, Singhal, MG, et al. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med 2006;130:1522–6.Google Scholar

Li, MK, Folpe, AL. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol 2004;11:101–5.Google Scholar

Werling, RW, Yaziji, H, Bacchi, CE, et al. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: An immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003;27:303–10.Google Scholar

Bobrow, LG, Happerfield, LC, Millis, RR. Comparison of immunohistological staining with different antibodies to the c-erbB-2 oncoprotein. Appl Immunohistochem 1996;4:128–34.Google Scholar

DePotter, CR. The new-oncogene: More than a prognostic indicator? Hum Pathol 1994;25:1264–8.Google Scholar

Beatty, WL, Morison, RP, Byrne, GI. Immunoelectron microscopic quantitation of differential levels of chlamydial proteins in cell culture model of persistent Chlamydia trachomatis infection. Infect Immun 1994;62:4059–62.Google Scholar

Hendy, GN, Bevan, S, Mattei, MG, et al. Chromogranin A. Clin Invest Med 1995;18:47–65.Google Scholar

Miettinen, M, Sarlomo-Rikala, M, Wang, ZF. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas. Am J Surg Pathol 2011;35(12):1848–56.Google Scholar

Vastrik, I, Makela, TP, Koskinen, PJ, et al. Myc protein: Partners and antagonists. Crit Rev Oncol 1994;5:59–68.Google Scholar

Birembaut, P, Caron, Y, Adnet, J-J. Usefulness of basement membrane markers in tumoral pathology. J Pathol 1985;145: 283–96.Google Scholar

Burkle, A, Neidermeier, M, Schmitt-Graff, A, et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B cell chronic lymphocytic leukemia. Blood 2007;110:3316–25.Google Scholar

Dupuis, J, Boye, K, Martin, N, et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T cell lymphoma (AITL): A new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 2006;30:490–4.Google Scholar

Nam-Cha, SH, Roncador, G, Sanchez-Verde, L, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol 2008;32:1252–7.Google Scholar

Ortonne, N, Dupuis, J, Plonquet, A, et al. Characterization of CXCL13+ neoplastic T cells in cutaneous lesions of angioimmunoblastic T cell lymphoma (AITL). Am J Surg Pathol 2007;31:1068–76.Google Scholar

Bartkova, J, Lukas, J, Strauss, M, et al. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994;172:237–45.Google Scholar

Battifora, H. Diagnostic uses of antibodies to keratins: A review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. In: Fenoglio-Preiser, CM, Wolff, M, Rilke, F. eds. Progress in surgical pathology, Vol. VIII. Springer-Verlag, Berlin, 1988, pp. 1–15.Google Scholar

Heatley, MK. Cytokeratins and cytokeratin staining in diagnostic histopathology (commentary). Histopathology 1996;28:479–83.Google Scholar

Miettinen, M. Keratin immunohistochemistry: Update of applications and pitfalls. In: Rosen, PP, Fechner, RE. eds. Pathology annual, Part 2/Vol 28. Appleton & Lange, New York, 1993, pp. 113–43.Google Scholar

Chu, PG, Weiss, LM. Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases. Mod Pathol 2002;15:6–10.Google Scholar

Chu, PG, Weiss, LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403–39.Google Scholar

Moll, R, Franke, WW, Schiller, DL, et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11–24.CrossRefGoogle ScholarPubMed

Ali, A, Serra, S, Asa, SL, et al. The predictive value of CK19 and CD99 in pancreatic endocrine tumors. Am J Surg Pathol 2006;30:1588–94.Google Scholar

Chetty, R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Arch Pathol Lab Med 2008;132:1285–9.Google Scholar

Deshpande, V, Fernandez-del Castillo, C, Muzikansky, A, et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 2004;28:1145–53.Google Scholar

Jain, R, Fischer, S, Serra, S, et al. The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem 2010;18:9–15.Google Scholar

Nechifor-Boila, A, Borda, A, Sassolas, G, et al. Immunohistochemical markers in the diagnosis of papillary thyroid carcinomas: The promising role of combined immunostaining using HBME-1 and CD56. Pathol Res Pract 2013;209:585–92.Google Scholar

Rosai, J. Immunohistochemical markers of thyroid tumors: Significance and diagnostic applications. Tumori 2003;89:517–19.Google Scholar

Ryu, HS, Lee, K, Shin, E, et al. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma. Tumori 2012;98:478–84.Google Scholar

Chan, JKC, Suster, S, Wenig, BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226–34.Google Scholar

Moll, R, Franke, WW, Schiller, DL, et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11–24.Google Scholar

Battifora, H. Diagnostic uses of antibodies to keratins: A review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. In: Fenoglio-Preiser, CM, Wolff, M, Rilke, F. eds. Progress in surgical pathology, Vol. VIII. Springer-Verlag, Berlin, 1988, pp. 1–15.Google Scholar

Battifora, H. Diagnostic uses of antibodies to keratins: A review and immunohistochemical comparison of seven monoclonal and three polyclonal antibodies. In: Fenoglio-Preiser, CM, Wolff, M, Rilke, F. eds. Progress in surgical pathology (Vol VIII), Springer-Verlag, Berlin, 1988, pp. 10–15.Google Scholar

Cooper, D, Schermer, A, Sun, T-T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications, and limitations. Lab Invest 1985;52:243–56.Google Scholar

Miettinen, M. Keratin immunohistochemistry: Update of applications and pitfalls. In: Rosen, PP, Fechner, RE. eds. Pathology Annual, Part 2/Vol 28. Appleton & Lange, New York, 1993, pp. 113–43.Google Scholar

Moll, R, Franke, WW, Schiller, DL, et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11–24.Google Scholar

Swenson, PD, Kaplan, MH. Rapid detection of cytomegalovirus in cell culture by indirect immunoperoxidase staining with monoclonal antibody to an early nuclear antigen. J Clin Microbiol 1985;21:669–73.Google Scholar

Zweygberg, WB, Wirgart, B, Grillner, L. Early detection of cytomegalovirus in cell culture by a monoclonal antibody. J Virol Methods 1986;14:65–9.Google Scholar

Anderson, P, Nagler-Anderson, C, O’Brien, C, et al. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990;144:574–82.Google Scholar